J. B. Chemicals & Pharmaceuticals Limited
Símbolo: JBCHEPHARM.NS
NSE
1743.85
INRPrecio de mercado actual
53.2431
Ratio PER
8.4545
Ratio PEG
270.64B
Capitalización MRK
- 0.01%
Rendimiento DIV
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2928.6 | 566.5 | 6936.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 2159.3 | 1.1 | 6649.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 5771.7 | 6238.8 | 4186.7 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 4304.9 | 4099.6 | 3474.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2275.1 | 1843.6 | 928.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 15280.3 | 12748.5 | 15526 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5764.2 | 5668.2 | 5696.6 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 574.6 | 574.6 | 574.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 13222.8 | 6713.9 | 321.1 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 13797.4 | 7288.5 | 895.6 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 137.8 | 127.2 | 129.1 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 65.1 | 64.3 | 69.4 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 493.9 | 177.2 | 64.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 20258.4 | 13325.5 | 6855.1 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 2386.4 | 2244.8 | 1869.2 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1739.1 | 339.4 | 398.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 49.5 | 60.9 | 79 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3985.4 | 206.2 | 51.4 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | 152.1 | 31.7 | 49.3 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 236.5 | 88.2 | 99.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5190.7 | 850.7 | 794.1 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 242.1 | 282.4 | 123.4 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 10735.2 | 4687.9 | 4246.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 154.8 | 154.6 | 154.6 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 22757.1 | 18427.1 | 15847.9 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2698.8 | 2248.4 | 1583.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -807.1 | 511.2 | 511.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 24803.5 | 21341.2 | 18097.2 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 44.9 | 37.1 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 24803.5 | 21386.1 | 18134.3 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 323.9 | 128.1 | 130.9 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5724.5 | 545.6 | 449.9 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | 4955.2 | -19.9 | 163 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5552.3 | 5049 | 5968.9 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1146.7 | -1685.9 | 0 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 693.7 | 626.5 | 0 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -299.2 | -3025.2 | -942.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | -417.5 | -2928.4 | -706 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -205.2 | -625.1 | -700.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 323.5 | 528.3 | 464.8 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 311.9 | 10.3 | -2565.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1998.6 | -7003.9 | -85 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -7568.7 | -5084.7 | -5412.1 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5570.1 | 12088.6 | 3169.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -1968.4 | 7091.1 | 498.9 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9617.9 | 23.2 | -2306.8 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -872.5 | -3.3 | -3.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 84.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 5684.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -1275.9 | -1275.6 | -732.4 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -55.8 | -105 | -138.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3565.4 | -1383.9 | -874.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | 0 | 0.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 203.9 | 340.7 | -32.8 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 769.3 | 565.4 | 224.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 565.4 | 224.7 | 257.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 6256.1 | 1701.3 | 3147.8 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -1393.4 | -5366.5 | 2670.1 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 31492.8 | 24242.4 | 20058.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3842.2 | 8633.7 | 7174.4 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 27650.6 | 15608.7 | 12884.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 13997.4 | 10862.7 | 8009.7 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3842.2 | 19496.5 | 15184.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 25.4 | 9.3 | 17.7 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5917.9 | 4739 | 4895.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 27650.6 | 5049 | 5968.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 893.1 | 1188.6 | 1483.6 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 4098.3 | 3853.6 | 4479.6 |
Preguntas frecuentes
Cuánto es J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) activos totales?
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) los activos totales son 35538700000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.890.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 14.157.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.152.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.855.
¿Qué es J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 4098300000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 5724500000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 13997400000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 0.000.